Metformin

Asian adults with type 2 diabetes were more than twice as likely as patients of other races to experience delayed treatment intensification when not meeting HbA1c goals, according to an analysis of electronic medical records data published in Current Medical Research and Opinion.

Use of metformin appeared to reduce the risk for varicose veins among adults with type 2 diabetes, according to findings from a retrospective cohort study published in Diabetes Metabolism Research and Reviews.

In Japanese adults with poorly controlled type 2 diabetes, high doses of metformin administered twice or three times daily improved fasting plasma glucose and 24-hour glycemic profile in a dose-dependent fashion, according to findings reported in the Journal of Diabetes Investigation.